UTHR vs. LQDA

Last updated Apr 1, 2026

Compare and contrast key facts about United Therapeutics Corporation (UTHR) and Liquidia Corporation (LQDA).

Performance

UTHR vs. LQDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Liquidia Corporation (LQDA). The values are adjusted to include any dividend payments, if applicable.

UTHR vs. LQDA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
UTHR United Therapeutics Corporation	21.70%	38.09%	60.46%	-20.93%	28.70%	42.35%	72.33%	-19.12%	-13.35%
LQDA Liquidia Corporation	9.42%	193.28%	-2.24%	88.85%	30.80%	65.08%	-30.99%	-80.26%	95.14%

Fundamentals

Market Cap UTHR : $28.40B LQDA : $3.78B
EPS UTHR : $27.90 LQDA : -$0.76
PS Ratio UTHR : 8.91 LQDA : 21.61
PB Ratio UTHR : 4.00 LQDA : 84.38
Total Revenue (TTM) UTHR : $3.18B LQDA : $158.32M
Gross Profit (TTM) UTHR : $2.80B LQDA : $153.90M
EBITDA (TTM) UTHR : $1.82B LQDA : -$45.21M

Returns By Period

In the year-to-date period, UTHR achieves a 21.70% return, which is significantly higher than LQDA's 9.42% return.

UTHR

• 1D: 0.79%
• 1M: 17.68%
• YTD: 21.70%
• 6M: 41.45%
• 1Y: 92.36%
• 3Y*: 38.34%
• 5Y*: 25.25%
• 10Y*: 18.04%

LQDA

• 1D: 7.28%
• 1M: 21.66%
• YTD: 9.42%
• 6M: 65.96%
• 1Y: 155.86%
• 3Y*: 76.11%
• 5Y*: 68.72%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

UTHR vs. LQDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR

UTHR Risk / Return Rank: 93
UTHR Sharpe Ratio Rank: 89
UTHR Sortino Ratio Rank: 94
UTHR Omega Ratio Rank: 94
UTHR Calmar Ratio Rank: 95
UTHR Martin Ratio Rank: 94

LQDA

LQDA Risk / Return Rank: 89
LQDA Sharpe Ratio Rank: 93
LQDA Sortino Ratio Rank: 89
LQDA Omega Ratio Rank: 86
LQDA Calmar Ratio Rank: 91
LQDA Martin Ratio Rank: 88

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. LQDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Liquidia Corporation (LQDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UTHR	LQDA	Difference
Sharpe ratio Return per unit of total volatility	1.84	2.28	-0.44
Sortino ratio Return per unit of downside risk	3.30	2.76	+0.54
Omega ratio Gain probability vs. loss probability	1.46	1.34	+0.12
Calmar ratio Return relative to maximum drawdown	5.70	3.97	+1.73
Martin ratio Return relative to average drawdown	14.49	9.04	+5.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UTHR vs. LQDA - Sharpe Ratio Comparison

The current UTHR Sharpe Ratio is 1.84, which is comparable to the LQDA Sharpe Ratio of 2.28. The chart below compares the historical Sharpe Ratios of UTHR and LQDA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	UTHR	LQDA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.84	2.28	-0.44
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.72	0.95	-0.23
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.51	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.20	+0.19

Correlation

The correlation between UTHR and LQDA is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

UTHR vs. LQDA - Dividend Comparison

Neither UTHR nor LQDA has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

UTHR vs. LQDA - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, roughly equal to the maximum LQDA drawdown of -93.87%. Use the drawdown chart below to compare losses from any high point for UTHR and LQDA.

Drawdown Indicators

	UTHR	LQDA	Difference
Max Drawdown Largest peak-to-trough decline	-93.18%	-93.87%	+0.69%
Max Drawdown (1Y) Largest decline over 1 year	-16.35%	-37.82%	+21.47%
Max Drawdown (5Y) Largest decline over 5 years	-33.00%	-55.36%	+22.36%
Max Drawdown (10Y) Largest decline over 10 years	-55.56%	—	—
Current Drawdown Current decline from peak	0.00%	-19.06%	+19.06%
Average Drawdown Average peak-to-trough decline	-35.53%	-71.10%	+35.57%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.43%	16.61%	-10.18%

Volatility

UTHR vs. LQDA - Volatility Comparison

United Therapeutics Corporation (UTHR) and Liquidia Corporation (LQDA) have volatilities of 17.05% and 16.81%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UTHR	LQDA	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.05%	16.81%	+0.24%
Volatility (6M) Calculated over the trailing 6-month period	26.84%	44.56%	-17.72%
Volatility (1Y) Calculated over the trailing 1-year period	50.41%	68.87%	-18.46%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.89%	72.66%	-36.77%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	35.32%	85.89%	-50.57%

Financials